Patents by Inventor Rod L. Rietze

Rod L. Rietze has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Generation of hematopoietic cells from multipotent neural stem cells
    Patent number: 7204979
    Abstract: Multipotent neural stem cell (MNSC) progeny are induced to generate cells of the hematopoietic system by placing the MNSC progeny in a hematopoietic-inducing environment. The hematopoietic-inducing environment can be either ex vivo or in vivo. A mammal's circulatory system provides an in vivo environment that can induce xenogeneic, allogeneic, or autologous MNSC progeny to generate a full complement of hematopoietic cells. Transplantation of MNSC progeny provides an alternative to bone marrow and hematopoietic stem cell transplantation to treat blood-related disorders.
    Type: Grant
    Filed: February 21, 2003
    Date of Patent: April 17, 2007
    Assignee: Neurospheres Holdings Ltd.
    Inventors: Christopher R. Bjornson, Rod L. Rietze, Brent A. Reynolds, Angelo L. Vescovi
  • Composition comprising multipotent neural stem cells for generation of hematopoietic cells
    Patent number: 6897060
    Abstract: Multipotent neural stem cell (MNSC) progeny are induced to generate cells of the hematopoietic system by placing the MNSC progeny in a hematopoietic-inducing environment. The hematopoietic-inducing environment can be either ex vivo or in vivo. A mammal's circulatory system provides an in vivo environment that can induce xenogeneic, allogeneic, or autologous MNSC progeny to generate a full complement of hematopoietic cells. Transplantation of MNSC progeny provides an alternative to bone marrow and hematopoietic stem cell transplantation to treat blood-related disorders.
    Type: Grant
    Filed: July 24, 2000
    Date of Patent: May 24, 2005
    Assignee: NeuroSpheres Holdings, Ltd.
    Inventors: Christopher R. Bjornson, Rod L. Rietze, Brent A. Reynolds, Angelo L. Vescovi
  • Use of multipotent neural stem cell progeny to augment non-neural tissues
    Patent number: 6638501
    Abstract: Multipotent neural stem cell (MNSC) progeny are transplanted into a recipient wherein they augment host tissue. The stem cells have a universal lineage potential and are capable of producing progeny that, in response to appropriate environmental signals, can differentiate into a variety of differentiated cell types, and not just neural lineages. MNSCs can be proliferated ex vivo to provide an unlimited supply of stem cells and stem cell progeny which give rise to the differentiated cell types of various tissues. The stem cells are readily amenable to genetic modification, if desired. They also have the advantage that they can be obtained from autologous adult human tissue and thus overcome prior art problems of transplant rejections.
    Type: Grant
    Filed: June 19, 1998
    Date of Patent: October 28, 2003
    Assignee: Neurospheres Holdings Ltd.
    Inventors: Christopher R. Bjornson, Rod L. Rietze, Brent A. Reynolds, Angelo L. Vescovi
  • Generation of hematopoietic cells from multipotent neutral stem cells
    Publication number: 20030148515
    Abstract: Multipotent neural stem cell (MNSC) progeny are induced to generate cells of the hematopoietic system by placing the MNSC progeny in a hematopoietic-inducing environment. The hematopoietic-inducing environment can be either ex vivo or in vivo. A mammal's circulatory system provides an in vivo environment that can induce xenogeneic, allogeneic, or autologous MNSC progeny to generate a full complement of hematopoietic cells. Transplantation of MNSC progeny provides an alternative to bone marrow and hematopoietic stem cell transplantation to treat blood-related disorders.
    Type: Application
    Filed: February 21, 2003
    Publication date: August 7, 2003
    Applicant: Neurosoheres Holdings Ltd.
    Inventors: Christopher R. Bjornson, Rod L. Rietze, Brent A. Reynolds, Angelo L. Vescovi
  • Generation of hematopoietic cells from multipotent neural stem cells
    Patent number: 6093531
    Abstract: Multipotent neural stem cell (MNSC) progeny are induced to generate cells of the hematopoietic system by placing the MNSC progeny in a hematopoietic-inducing environment. The hematopoietic-inducing environment can be either ex vivo or in vivo. A mammal's circulatory system provides an in vivo environment that can induce xenogeneic, allogeneic, or autologous MNSC progeny to generate a full complement of hematopoietic cells. Transplantation of MNSC progeny provides an alternative to bone marrow and hematopoietic stem cell transplantation to treat blood-related disorders.
    Type: Grant
    Filed: June 19, 1998
    Date of Patent: July 25, 2000
    Assignee: NeuroSpheres Holdings Ltd.
    Inventors: Christopher R. Bjornson, Rod L. Rietze, Brent A. Reynolds, Angelo L. Vescovi